Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd Deal History & Licensing Activity
Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd is a life sciences. Over the past three years, Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd has been involved in 8 licensing and acquisition transactions, with a primary focus on Small Molecules (8 deals).
Deals (12mo)
6
Active Trials
0
Top Modality
Small Molecules
Focus Area
Mega Deals
Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| BTK degrader program | Roche | Small Molecules | Unknown | collaboration | Jun 9, 2026 |
| Poseida cell-therapy platform | Roche | Cell Therapy | Unknown | acquisition | May 24, 2026 |
| PathAI digital pathology and AI diagnostic platform | Roche | Other | Unknown |
Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd Pipeline Focus
Therapeutic areas and modalities where Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Cell Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for cell therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd Licensing & Deal Activity
Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 8 deals over the past three years, Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd include Mega Deals (8 deals and trials), Codev Deals (4 deals and trials), and Option Deals (1 deal and trial). In terms of modality, Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd has shown particular interest in small molecules, cell therapy, other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.